|
Market Research Report
U.S. Human Growth Hormone Market
| Published by |
Frost & Sullivan |
| Published |
August, 2008 |
Product code |
72408 |
| Content info |
76 Pages |
| Price |
|
|
U.S. Human Growth Hormone Market published by Frost & Sullivan in August, 2008. This report consists of 76 Pages and the price starts from US $ 6000.
Abstract
This research service analyzes the changing dynamics in the U.S. human growth
hormone market for the period 2004-2014. Included are a pipeline analysis,
revenue forecast, patient forecast, market share analysis, product analysis
and major trends such as drivers, challenges and restraints. The market is
segmented by adult and pediatric. Overviews of the diseases and indications
treated by human growth hormone are also provided along with current and
future market landscape.
Table of Contents
1. U.S. HUMAN GROWTH HORMONE MARKET
Overview
- Title
- Disclaimer and Certification
- Table of Contents
- Notes on Methodology
Market Introduction
- Market Introduction
- Human Growth Hormone: Definition
- Human Growth Hormone Market: Market Overview
- Product Analysis
- Competitive Structure
Disease Overview and Drug Delivery Systems
- Disease Overview and Drug Delivery Systems
- FDA Approved Indications
- Disease Overview
- Therapy Guidelines
- Pediatric Human Growth Hormone Market
- Adult Human Growth Hormone Market
- Drug Delivery Systems
New Indications and Challenges
- Idiopathic Short Stature
- Small for Gestational Age
Hot Topics
- Hot Topics
- The Debate on Bio-generics
- Product Off-label and Investigational Uses
- Debate on Off-label Use of Growth Hormone
Market Trends
- Market Trends
- Industry Challenges
- Market Drivers
- Market Restraints
Revenue Analysis
- Revenue Analysis
- Market Engineering Measurements
- Patient Forecast
- Therapy Cost and Treatment Patterns
- Annual Treatment Costs Forecast
- Revenue Forecasts
Market Share Analysis
- Market Share Analysis
- Company Market Share
- Market Share Discussion
Clinical Developments and Pipeline
- Clinical Developments and Pipeline
- Clinical Developments
- Ongoing Clinical Trials for Marketed Products
Company Profiles
- Company Profiles
- Genentech
- Eli Lilly
- Pfizer
- Novo Nordisk
- EMD Serono
- Teva Pharmaceuticals
- Sandoz
Conclusion
- Conclusion
- Future Competitive Landscape
About Frost & Sullivan
|
